Company Filing History:
3 out of 3 
3 out of 3 Years Active: 2024-2025
Title: Xueying Wu: Innovator in Tumor Detection Technologies
Introduction
Xueying Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumors. With a total of 3 patents, his work focuses on innovative reagent compositions that enhance the accuracy of tumor detection.
Latest Patents
Xueying Wu's latest patents include a reagent composition for the detection of non-hematopoietic tumors. This invention provides a comprehensive set of antibodies designed for flow cytometry screening, diagnosis, and follow-up detection of such tumors. The reagent composition consists of three sets of antibodies, each targeting specific markers to improve detection accuracy. His second patent involves a detection reagent and therapeutic target for B cell tumors after targeted therapy. This composition also includes multiple groups of antibodies aimed at facilitating the detection of B-lymphocyte tumors through flow cytometry.
Career Highlights
Throughout his career, Xueying Wu has worked with notable organizations, including Synarc Research Laboratory and Hebei Yanda Ludaopei Hospital. His experience in these institutions has allowed him to develop and refine his innovative approaches to tumor detection.
Collaborations
Xueying Wu has collaborated with several professionals in his field, including Hui Wang and Man Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Xueying Wu's contributions to tumor detection technologies exemplify the impact of innovation in the medical field. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patient care and treatment outcomes.